181 related articles for article (PubMed ID: 23856321)
21. In vitro activity of organometallic complexes of Ir, Pt and Rh on Trypanosoma b. gambiense, T. b. rhodesiense and T. b. brucei.
Zinsstag J; Brun R; Craciunescu DG; Parrondo Iglesias E
Trop Med Parasitol; 1991 Mar; 42(1):41-4. PubMed ID: 2052855
[TBL] [Abstract][Full Text] [Related]
22. In vitro drug sensitivity of Trypanosoma gambiense isolates.
Brun R; Baeriswyl S; Kunz C
Acta Trop; 1989 Oct; 46(5-6):369-76. PubMed ID: 2575872
[TBL] [Abstract][Full Text] [Related]
23. The establishment of in vitro culture and drug screening systems for a newly isolated strain of Trypanosoma equiperdum.
Suganuma K; Yamasaki S; Molefe NI; Musinguzi PS; Davaasuren B; Mossaad E; Narantsatsral S; Battur B; Battsetseg B; Inoue N
Int J Parasitol Drugs Drug Resist; 2017 Aug; 7(2):200-205. PubMed ID: 28437733
[TBL] [Abstract][Full Text] [Related]
24. Screening a Natural Product-Based Library against Kinetoplastid Parasites.
Zulfiqar B; Jones AJ; Sykes ML; Shelper TB; Davis RA; Avery VM
Molecules; 2017 Oct; 22(10):. PubMed ID: 29023425
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy of human African trypanosomiasis.
Burchmore RJ; Ogbunude PO; Enanga B; Barrett MP
Curr Pharm Des; 2002; 8(4):256-67. PubMed ID: 11860365
[TBL] [Abstract][Full Text] [Related]
26. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro.
Räz B; Iten M; Grether-Bühler Y; Kaminsky R; Brun R
Acta Trop; 1997 Nov; 68(2):139-47. PubMed ID: 9386789
[TBL] [Abstract][Full Text] [Related]
27. A luciferase based viability assay for ATP detection in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427.
Sykes ML; Avery VM
Parasit Vectors; 2009 Nov; 2(1):54. PubMed ID: 19909542
[TBL] [Abstract][Full Text] [Related]
28. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
29. Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice.
Pyana PP; Ngay Lukusa I; Mumba Ngoyi D; Van Reet N; Kaiser M; Karhemere Bin Shamamba S; Büscher P
PLoS Negl Trop Dis; 2011 Apr; 5(4):e1025. PubMed ID: 21526217
[TBL] [Abstract][Full Text] [Related]
30. Long-term exposure of Trypanosoma brucei gambiense to pentamidine in vitro.
Miézan TW; Bronner U; Doua F; Cattand P; Rombo L
Trans R Soc Trop Med Hyg; 1994; 88(3):332-3. PubMed ID: 7974681
[TBL] [Abstract][Full Text] [Related]
31. Trypanocidal effect of Ir-(COD)-pentamidine tetraphenylborate on Trypanosoma brucei and T. b. gambiense rodent models and serum kinetics in sheep.
Loiseau PM; Dreyfuss G; Daulouède S; Lachâtre G; Vincendeau P; Craciunescu DG
Trop Med Int Health; 1997 Jan; 2(1):19-27. PubMed ID: 9018299
[TBL] [Abstract][Full Text] [Related]
32. Recent progress in diagnosis and treatment of Human African Trypanosomiasis has made the elimination of this disease a realistic target by 2030.
Álvarez-Rodríguez A; Jin BK; Radwanska M; Magez S
Front Med (Lausanne); 2022; 9():1037094. PubMed ID: 36405602
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of proline derived benzenesulfonamides: A potent anti-Trypanosoma brucei gambiense agent.
Ugwu DI; Okoro UC; Mishra NK
Eur J Med Chem; 2018 Jun; 154():110-116. PubMed ID: 29778893
[TBL] [Abstract][Full Text] [Related]
34. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R
Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
[TBL] [Abstract][Full Text] [Related]
35. Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model.
Dauchy FA; Bonhivers M; Landrein N; Dacheux D; Courtois P; Lauruol F; Daulouède S; Vincendeau P; Robinson DR
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005125. PubMed ID: 27855164
[TBL] [Abstract][Full Text] [Related]
36. Development of multiplex serological assay for the detection of human African trypanosomiasis.
Nzou SM; Fujii Y; Miura M; Mwau M; Mwangi AW; Itoh M; Salam MA; Hamano S; Hirayama K; Kaneko S
Parasitol Int; 2016 Apr; 65(2):121-7. PubMed ID: 26519611
[TBL] [Abstract][Full Text] [Related]
37. Trypanosome alternative oxidase, a potential therapeutic target for sleeping sickness, is conserved among Trypanosoma brucei subspecies.
Nakamura K; Fujioka S; Fukumoto S; Inoue N; Sakamoto K; Hirata H; Kido Y; Yabu Y; Suzuki T; Watanabe Y; Saimoto H; Akiyama H; Kita K
Parasitol Int; 2010 Dec; 59(4):560-4. PubMed ID: 20688188
[TBL] [Abstract][Full Text] [Related]
38. Diverse effects on mitochondrial and nuclear functions elicited by drugs and genetic knockdowns in bloodstream stage Trypanosoma brucei.
Worthen C; Jensen BC; Parsons M
PLoS Negl Trop Dis; 2010 May; 4(5):e678. PubMed ID: 20454560
[TBL] [Abstract][Full Text] [Related]
39. Antiprotozoal and cytotoxic screening of 45 plant extracts from Democratic Republic of Congo.
Mesia GK; Tona GL; Nanga TH; Cimanga RK; Apers S; Cos P; Maes L; Pieters L; Vlietinck AJ
J Ethnopharmacol; 2008 Feb; 115(3):409-15. PubMed ID: 18068320
[TBL] [Abstract][Full Text] [Related]
40. Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study.
Büscher P; Mertens P; Leclipteux T; Gilleman Q; Jacquet D; Mumba-Ngoyi D; Pyana PP; Boelaert M; Lejon V
Lancet Glob Health; 2014 Jun; 2(6):e359-63. PubMed ID: 25103304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
